<DOC>
	<DOCNO>NCT02499718</DOCNO>
	<brief_summary>Assessment effect safety noninvasive positive pressure ventilation severe stable chronic obstructive pulmonary disease</brief_summary>
	<brief_title>Non-invasive Positive Pressure ( NPPV ) Severe Stable Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Hypercapnia</mesh_term>
	<criteria>clinically stable , hypercapnic GOLD stage IV COPD , age 18 year old , baseline arterial carbon dioxide pressure ( PaCO2 ) 6.7 kPa ( 50 mmHg ) high pH high 7·35 , measure least 1 h rest sit position . thorax lung COPD No smoking Cigarette≤10/day obesity bodymass index ( BMI ) ≥40 kg/m² malignant comorbidities , severe heart failure ( New York Heart Association stage IV ) , unstable angina , severe arrhythmia .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Non-invasive positive pressure ventilation</keyword>
	<keyword>quality life</keyword>
	<keyword>long-term oxygen therapy</keyword>
</DOC>